Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins

• Status: Completed
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Recent evidences showed beneficial effects of omega-3 fatty acids on cardiovascular morbidity and mortality.

Regular Omega-3 fatty acid consumption reduces cardiovascular mortality, ischemic heart disease and stroke mortality. There is probably no single mechanism of action that explains this beneficial effect; but possible mechanisms include reduce susceptibility of the heart to ventricular arrhythmia, antithrombogenic effect, reduce triglyceride level, promotion of nitric oxide-induced endothelial relaxation, and retard growth of atherosclerotic plaque.

The combination of satins and omega3 was proved to be better the any of the drugs alone in several studies.

The purpose of the study is to investigate several possible mechanisms that may explain the add on beneficial effect of omega-3 in hypercholesterolemic patients already treated with satins.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assaf-Harofeh Medical Center

Criteria

Inclusion Criteria:

• dyslipidemia controlled (LDL < 130)

• statin treatment

• triglycerides < 200

• informed consent

Exclusion Criteria:

• thrombocytopenia or bleeding tendency

• uncontrolled diabetes mellitus

• uncontrolled hypertension (systolic > 160 or diastolic > 100)

• omega 3 pretreatment

• recent acute coronary syndrome or cerebrovascular event (less than 3 months)